Signs in Biological Technology

LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit

... Pharma A/S - was well tolerated and showed early signs of clinical benefit in previously treated cancer ... that EZN-2968 is well tolerated, and that early signs of clinical benefit - prolonged stable disease - ... LNA-based RNA inhibitors are beginning to show signs of clinical benefit in cancer patients is very ...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... (infliximab). Cimzia(R) is approved for reducing signs and symptoms of moderate to severe Crohn's ... (FDA) has approved Cimzia(R) for reducing signs and symptoms of Crohn's disease and maintaining ... be closely monitored for the development of signs and symptoms of infection during and after ...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... with moderately to severely active RA; reducing signs and symptoms in adult patients with moderately to ... alone or in combination with MTX; and reducing signs and symptoms in adult patients with active AS who ... found SIMPONI to be effective in reducing the signs and symptoms of RA, PsA and AS. About ...

AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

... arteries.(1) However, athero typically has no signs or symptoms until an artery becomes severely ... the disease progresses silently, with no visible signs or symptoms.(2) Athero is the leading cause of ... JAMA. 1999; 281 (8): 727-735. (2) "What are the signs and Symptoms of Atherosclerosis?" National Heart, ...

Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers

... Lotion (Pyratine XR(TM)) for Improving the signs and Symptoms of Rosacea," at the March 8th ... treatments that provide sustained relief of the signs and symptoms of rosacea are needed. Eighteen ... in improving the clinical signs and symptoms of rosacea. Subjects were evaluated ...

Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel

... will be used in clinical trials to reveal early signs and locations of drug-induced kidney damage, ... however, suggest these tests detect only late signs of kidney damage and provide no information on ... same biomarkers and is designed to detect general signs of kidney damage. Drugs in circulation are ...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

... CIMZIA(R) is indicated for reducing the signs and symptoms of Crohn's disease and maintaining ... CIMZIA(R) was approved in April 2008 for reducing signs and symptoms of Crohn's disease and maintaining ... . Monitor patients receiving CIMZIA (R) for signs and symptoms of active tuberculosis, including ...

One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study

... at least 20 percent improvement in arthritis signs and symptoms as measured by American College of ... Quality of Life In addition to improvements in signs and symptoms of psoriatic arthritis, patients ... of golimumab extends beyond the categories of signs and symptoms and improved the lives of patients ...

Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis

... improvements in rheumatoid arthritis (RA) signs and symptoms based on American College of ... "These data demonstrate improvement in RA signs and symptoms and, combined with data from more ... to, the risk that significant improvement in RA signs and symptoms will not be observed after further ...

Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritis

... (MTX) experienced significant improvements in the signs and symptoms of rheumatoid arthritis (RA) as well ... MTX achieved at least 20 percent improvement in signs and symptoms of RA (ACR 20), compared to 33 ... combination with MTX experienced improvement in signs and symptoms of arthritis as well as in disease ...

Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data

... duration being 16 weeks. Encouraging early signs of anti-tumor activity include demonstrable ... disease in several patients, as well as objective signs of tumor responses, and signs of improvement in disease-related sequelae in ...

Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis

... REVEAL and CHAMPION. In both trials, the signs and symptoms of psoriasis were measured and ... experienced a significant reduction in the signs and symptoms of their disease at 16 weeks when ... experienced a significant reduction in the signs and symptoms of their disease compared with ...

REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide

... as the first and only biologic for reducing signs and symptoms, achieving clinical remission ... first and only biologic indicated to reduce signs and symptoms and induce and maintain clinical ... with methotrexate, is indicated for reducing signs and symptoms, inhibiting the progression of ...

NicOx Opens U.S. Headquarters in New Jersey

... Oxide Donator (CINOD) for the treatment of the signs and symptoms of osteoarthritis. Sanjiv Sharma, ... 3 clinical development for the treatment of the signs and symptoms of osteoarthritis. Results from the ... in phase 3 development for the treatment of signs and symptoms of osteoarthritis, and NCX 4016, in ...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing

... absolutely no sign of corrosion. All the other solutions exhibited clear signs of chemical reaction with the steel wool, including at least one of the ... which contains no corrosion inhibitors was completely inert and showed no signs of corrosion in the twelve day test we conducted." "This is an ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... of SIMPONI every four weeks provided persistent improvements in the signs and symptoms in patients with psoriatic arthritis and ankylosing ... of SIMPONI every four weeks experienced significant improvements in signs and symptoms compared with patients receiving placebo. (Announced June ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... and Transplantation Drug Test from Abbott II-86 Encorium Group signs Contract with Global Biopharmaceutical Company II-86 Paladin signs an Agreement with Watson for Supply and Sale of Trelstar(R) II-87 ...

FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout

... is gout in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with conventional urate-lowering ... with treatment failure gout, to control hyperuricemia and to manage the signs and symptoms of gout. Savient has exclusively licensed worldwide rights to ...

Bionovo Announces 2008 Highlights and Year-End Financial Results

... favorable tolerability and safety profile, and exhibiting encouraging signs of positive efficacy. Further results from this study were ... presented at the San Antonio Breast Cancer Symposium, indicating promising signs of potential efficacy for both cancer drug candidates. ...

The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment

... years, the Coalition has made great strides in raising awareness of the signs and symptoms of DVT on both a national and grassroots level," said Melanie ... professionals and policy-makers about risk factors, symptoms and signs associated with DVT, as well as identify evidence-based measures to reduce ...

Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value

... for naproxcinod, its lead investigational drug for the treatment of the signs and symptoms of osteoarthritis (OA). Michele Garufi, Chief ... Oxide-Donating (CINOD) anti-inflammatory agent for the treatment of the signs and symptoms of osteoarthritis. Naproxcinod has completed three pivotal ...

Mouse study reveals genetic component of empathy

... For example, nonverbal social cues are frequently used to identify early signs of autism in very young children. "The core of empathy is being able ... chamber and presented with the tone, they exhibited clear physiological signs of aversion, such as freezing in place, even though no shock was ....

Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder

... heels of the FDA approval of RAPAFLOTM (silodosin), a treatment for the signs and symptoms of benign prostatic hyperplasia (BPH), and the acceptance of ... parallel group trial that evaluated a total of 789 patients with signs and symptoms of OAB. Over the 12-week trial, a one-gram, once-daily dose ...

Tips from the journals of the American Society for Microbiology

... following intragastric and subcutaneous inoculation without any clinical signs of disease. The previously inoculated mice were then challenged ... At day fourteen women in the probiotic group were displaying no clinical signs of mastitis, but infection in the control group persisted. Finally, on ...

Tips from the journals of the American Society for Microbiology

... following intragastric and subcutaneous inoculation without any clinical signs of disease. The previously inoculated mice were then challenged ... At day fourteen women in the probiotic group were displaying no clinical signs of mastitis, but infection in the control group persisted. Finally, on ...

ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)

... of response and in certain secondary endpoints measuring additional signs or symptoms of ocular allergy, including improvement in nasal symptoms. ... of action are believed to make it an effective treatment against the signs and symptoms of allergic conjunctivitis. Bepotastine was approved in ...

NicOx' Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen

... demonstrate that it is safe, well tolerated and effective for treating the signs and symptoms of osteoarthritis, in addition to having no detrimental ... agents, which is in phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase 3 results anticipated in ...

Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis

... despite ongoing treatment with methotrexate. "In addition to reducing signs and symptoms, these data show improvement in important measures of ... people in the United States and more than three million people in Europe. signs and symptoms of RA include pain, stiffness and motion restriction in ...

Savient's Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference

... in the OLE continued to show improvements in the resolution of their signs and symptoms of treatment-failure gout with continuing pegloticase ... the control of uric acid, but more importantly for the amelioration of the signs and symptoms of disease. If approved, pegloticase would be an important ...

NicOx Reports Results for the First Three Quarters of 2008

... drug which is in late phase 3 studies for the treatment of the signs and symptoms of osteoarthritis. For the nine months ended September 30, ... agents, which is in phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase 3 results anticipated in ...

Lilly to Take Charge to Earnings Related to Pending Federal and State Investigations of Past Practices

... as Neuroleptic Malignant Syndrome NMS has been reported with Zyprexa. If signs and symptoms appear, immediate discontinuation is recommended. Clinical ... pressure, tachycardia, diaphoresis and cardiac dysrhythmia). Additional signs may include elevated creatinine phosphokinase, myoglobinuria ...

Nu Skin Scientists Correlate the Appearance of Aging With arNOX Free Radical Generator

... age, on average. "Demonstrating arNOX as a source of certain visible signs of aging validates our strategic focus of attacking the sources of aging," ... that inhibits arNOX activity, and thus slows the appearance of certain signs of aging," said Ashok Pahwa, chief marketing officer at Nu Skin. ...

Tips from the journals of the American Society for Microbiology

... following intragastric and subcutaneous inoculation without any clinical signs of disease. The previously inoculated mice were then challenged ... At day fourteen women in the probiotic group were displaying no clinical signs of mastitis, but infection in the control group persisted. Finally, on ...

Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder

... Bleeding Disorders, educates women about VWD by shining light on the signs and symptoms of the disease which can often present in childhood and ... doctor immediately if they suspect they have symptoms." Know the Five signs of a Bleeding Disorder -- Easy bruising of the limbs -- Frequent or ...

NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules

... demonstrate that it is safe, well tolerated and effective for treating the signs and symptoms of osteoarthritis, in addition to having no detrimental ... agents, which is in phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase 3 results anticipated in ...

Hoana Medical and Hawai'i Union Health and Welfare Trust Funds Partner to Fix Healthcare

... and respiratory arrests and vital sign changes, with warning signs preceding events by an average of 6 - 8 hours" (Joint Commission, 2007). ... any hospital bed into a LifeBed(TM) System by tracking a patient's vital signs without any wires or connections to the patient. At the intersection ...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

... for cardiac failure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and ... of GI bleeds. Patients should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or life-threatening. There ...

Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients

... personalized daily interactions and questions, while collecting vital signs and transmitting the information directly into a database. It is uniquely ... Regular data input and monitoring enables the health care team to detect signs and symptoms of change as they occur. "We are very excited about this ...

Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia

... for cardiac failure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and ... impairment. Patients should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or life-threatening. There ...

Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows

... of Health Guidelines for the Diagnosis and Management of Asthma, signs of poor asthma control include waking at night with asthma symptoms, trips ... include shortness of breath, wheezing, chest tightness, or cough. Other signs of asthma can include a persistent cough at night; difficulty breathing ...